What's Happening?
The United States is entirely dependent on imports for holmium, a critical rare earth element essential for advanced medical devices like holmium surgical lasers used in prostate surgery. Despite the existence of American manufacturers for these lasers and
the crystals they use, the holmium itself is overwhelmingly sourced from China. According to the United States Geological Survey’s Mineral Commodity Summaries 2026, China accounted for 100 percent of identifiable American imports of holmium compounds and metals from 2021 through 2024. This reliance highlights a significant vulnerability in the U.S. critical minerals supply chain, as the industrial capability to recover, separate, and purify holmium from domestic resources to the required specifications for medical applications is currently lacking.
Why It's Important?
This dependency poses a substantial risk to the U.S. healthcare system and national security. Holmium lasers are vital for common medical procedures, and a disruption in the supply of this rare earth element could severely impact the availability of these life-saving technologies. The issue extends beyond mere mining; it encompasses industrial organization, technical competence, materials qualification, and the preservation of manufacturing capability. The economic importance of holmium in this context is not measured by the quantity consumed, which is small, but by the severe consequences of its unavailability. Manufacturers cannot easily substitute materials or suppliers due to stringent regulatory and engineering requirements, making the supply chain highly sensitive to disruptions.
What's Next?
Addressing this vulnerability requires a comprehensive approach that goes beyond simply identifying mineral resources. The U.S. needs to develop the industrial capability to process holmium from raw materials, separate it from other rare earths, and purify it to the precise specifications required by medical device manufacturers. This involves examining actual procurement relationships, materials specifications, supplier qualification records, and manufacturing practices to understand the full scope of the supply chain. Future industrial policy should prioritize financing the development of processing capabilities that are directly linked to the requirements of finished product manufacturers, ensuring that any domestic production can meet the specific needs of industries like medical technology.
Beyond the Headlines
The case of holmium illustrates a broader problem in the U.S. critical minerals strategy, which has often focused on rare earths for permanent magnets while overlooking other technologically indispensable applications. This oversight creates hidden vulnerabilities in critical sectors like healthcare. The challenge is not just about mining but about building a complete industrial ecosystem that can transform raw materials into high-purity, application-specific components. This situation also raises questions about the transparency and traceability of critical mineral supply chains, as the exact origin of holmium in specific medical devices remains unclear. A more robust and diversified critical minerals strategy is needed to ensure the resilience of essential U.S. industries.













